FR3135893B1 - utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique - Google Patents

utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique Download PDF

Info

Publication number
FR3135893B1
FR3135893B1 FR2305321A FR2305321A FR3135893B1 FR 3135893 B1 FR3135893 B1 FR 3135893B1 FR 2305321 A FR2305321 A FR 2305321A FR 2305321 A FR2305321 A FR 2305321A FR 3135893 B1 FR3135893 B1 FR 3135893B1
Authority
FR
France
Prior art keywords
skeletonema
polar extract
photodynamic therapy
polar
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2305321A
Other languages
English (en)
Other versions
FR3135893A1 (fr
Inventor
Jean-Baptiste Berard
Louise Lefoulon
Laurent Picot
Tan-Sothea Ouk
Naïma Saad
Cornelia Landolt
Karine Grenier
Vincent Sol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Francais De Rech Pour Lexploitation de la Mer
Centre National de la Recherche Scientifique CNRS
Institut Francais de Recherche pour lExploitation de la Mer (IFREMER)
Universite de Limoges
La Rochelle Universite
Original Assignee
Institut Francais De Rech Pour Lexploitation de la Mer
Centre National de la Recherche Scientifique CNRS
Institut Francais de Recherche pour lExploitation de la Mer (IFREMER)
Universite de Limoges
Universite de la Rochelle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Francais De Rech Pour Lexploitation de la Mer, Centre National de la Recherche Scientifique CNRS, Institut Francais de Recherche pour lExploitation de la Mer (IFREMER), Universite de Limoges, Universite de la Rochelle filed Critical Institut Francais De Rech Pour Lexploitation de la Mer
Priority to FR2305321A priority Critical patent/FR3135893B1/fr
Publication of FR3135893A1 publication Critical patent/FR3135893A1/fr
Application granted granted Critical
Publication of FR3135893B1 publication Critical patent/FR3135893B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L’invention concerne un kit destiné à un traitement photodynamique, lequel comprend :1) une composition dermatologique comprenant au moins un extrait polaire d’une algue du genre Skeletonema ou un photosensibilisateur dérivé de celui-ci ;2) une source lumineuse.
FR2305321A 2020-04-14 2023-05-30 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique Active FR3135893B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2305321A FR3135893B1 (fr) 2020-04-14 2023-05-30 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR2003712 2020-04-14
FR2003712A FR3109086B1 (fr) 2020-04-14 2020-04-14 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique
FR2305321A FR3135893B1 (fr) 2020-04-14 2023-05-30 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
FR2003712A Division FR3109086B1 (fr) 2020-04-14 2020-04-14 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique

Publications (2)

Publication Number Publication Date
FR3135893A1 FR3135893A1 (fr) 2023-12-01
FR3135893B1 true FR3135893B1 (fr) 2024-09-27

Family

ID=72709416

Family Applications (2)

Application Number Title Priority Date Filing Date
FR2003712A Active FR3109086B1 (fr) 2020-04-14 2020-04-14 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique
FR2305321A Active FR3135893B1 (fr) 2020-04-14 2023-05-30 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR2003712A Active FR3109086B1 (fr) 2020-04-14 2020-04-14 utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique

Country Status (9)

Country Link
US (1) US20230241142A1 (fr)
EP (1) EP4135768A1 (fr)
JP (1) JP7793148B2 (fr)
KR (1) KR20230002645A (fr)
CN (1) CN115379857A (fr)
BR (1) BR112022020932A2 (fr)
FR (2) FR3109086B1 (fr)
WO (1) WO2021209441A1 (fr)
ZA (1) ZA202210407B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024057032A1 (fr) * 2022-09-14 2024-03-21 I-Smart Developments Limited Système et méthode de traitement cutané
EP4739279A1 (fr) 2023-07-07 2026-05-13 Fermentalg Extrait de biomasse d'algues rouges et son utilisation cosmetique pour eliminer les imperfections de la peau

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330741A (en) * 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
FR2782921B1 (fr) * 1998-09-09 2002-09-20 Dior Christian Parfums Extrait lipidique de l'algue skeletonema, procede de preparation et utilisation dans des domaines cosmetique et pharmaceutique, notamment dermatologique
FR2791568B1 (fr) * 1999-04-02 2004-04-02 Lvmh Rech Composition cosmetique comprenant au moins une subtance favorisant la formation de connexine, utilisation et procede de traitement cosmetique
AU2002312154B2 (en) 2001-06-01 2008-05-15 Biolitec Pharma Marketing Ltd Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
CA2457214A1 (fr) 2004-02-06 2005-08-06 Qlt Inc. Therapie photodynamique pour le traitement de l'acne
MX2007000338A (es) 2004-06-09 2007-03-28 Quadra Logic Tech Inc Terapia fotodinamica para el tratamiento de trastornos hiperactivos de glandulas sebaceas.
CA2684091A1 (fr) 2007-05-04 2008-11-13 Galderma Research & Development Utilisation d'un derive d'acide naphtoique combinee a une lumiere rouge et/ou bleue dans le traitement d'acne vulgaire
EP3082787B1 (fr) 2013-12-20 2020-11-25 Galderma Research & Development Traitement photodynamique par impulsions pour la peau abîmée par le soleil

Also Published As

Publication number Publication date
FR3109086A1 (fr) 2021-10-15
FR3135893A1 (fr) 2023-12-01
WO2021209441A1 (fr) 2021-10-21
JP2023529257A (ja) 2023-07-10
KR20230002645A (ko) 2023-01-05
ZA202210407B (en) 2023-05-31
FR3109086B1 (fr) 2025-10-24
CN115379857A (zh) 2022-11-22
BR112022020932A2 (pt) 2023-03-14
US20230241142A1 (en) 2023-08-03
JP7793148B2 (ja) 2026-01-05
EP4135768A1 (fr) 2023-02-22

Similar Documents

Publication Publication Date Title
MA57825B1 (fr) Tétrahydrofuranes substitués en tant que modulateurs de canaux sodiques
MA64121B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
WO2020252397A8 (fr) Chimères ciblant la protéolyse à petites molécules et leurs méthodes d'utilisation
MA47079B1 (fr) Composés amino-triazolopyidines et leur utilisation pour traiter le cancer
WO2018229236A3 (fr) Compositions comprenant des souches bactériennes
BR112016018205A8 (pt) métodos de tratamento de mal de alzheimer, de seleção de pacientes, de identificação de pacientes, de previsão, de otimização da eficácia terapêutica, kit, uso de agente e uso in vitro de agente
MA40290A1 (fr) Agents immunorégulateurs
NO20080785L (no) Behandling av kreft
MA43335B1 (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
MX2008006076A (es) Metodos, composiciones y kits para el tratamiento de condiciones medicas.
WO2004024097A8 (fr) Compositions et methodes de traitement de maladies de nature immune
AR048135A1 (es) Uso de gen de amiloide a serico en el diagnostico y tratamiento del glaucoma y en la identificacion de agentes anti-glaucoma.
EP4566629A3 (fr) Utilisation d'un échange de plasma à faible volume pour le traitement de la maladie d'alzheimer dans des stades précoces et intermédiaires
MX2022008201A (es) Construcciones mejoradas de aav-abcd1 y su uso para su tratamiento o prevención de adrenoleucodistrofia (ald) y/o adrenomieloneuropatía (amn).
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
PH12022550818A1 (en) Biomarker-based treatment of focal segmental glomerulosclerosis and diabetic kidney disease
MA28567B1 (fr) Utilisation de beta-carbolines pour le traitement de maladies inflammatoires
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
WO2019016597A3 (fr) Protéines synthétiques et leurs utilisations thérapeutiques
EA202193038A1 (ru) Антитела против sema3a и их применения для лечения заболеваний глаз
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
BR0211635A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer
MA56998B1 (fr) Traitement de symptômes induits par le cycle menstruel
FR3109086B1 (fr) utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique
WO2018201007A3 (fr) Compositions de dendrimères destinées à être utilisées en angiographie

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLSC Publication of the preliminary search report

Effective date: 20240119

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7